The alternating hypothesis suggests that cycling between a pure GLP-1 agonist and a dual GIP/GLP-1 agonist could prevent or delay this tolerance
Visit one of our Aspen Clinic locations, including Prairieville, Lafayette, Harvey, Houma, Hammond, Covington, Metairie, Slidell, and Baton Rouge
NIH describes the cardiovascular implications as uncertain but concerning enough to discuss with a clinician if you have heart disease risk, high LDL cholesterol, kidney disease, or plan to use high doses for months
But this also creates a paradox: some companies or providers may see reduced volumes or sales of these high-cost services, posing challenges to traditional healthcare business modelssomething management teams and healthcare investors are watching very closely